Low Sugar Protein Pacing + Intermittent Fasting for Weight Loss
What You Need to Know Before You Apply
What is the purpose of this trial?
The trial aims to explore how a combination of protein pacing (eating protein regularly throughout the day) and intermittent fasting affects body composition, blood sugar, and other health markers in people who are overweight or obese. Participants will try different eating plans over eight weeks, including one that mixes protein-focused meals with fasting days (PP-IF) and another that follows heart-healthy dietary guidelines (HH). The trial seeks non-smoking adults who have been overweight for at least six months and are not very active.
As an unphased study, this trial offers a unique opportunity to contribute to understanding innovative dietary approaches for improving health.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the study team or your doctor.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that both protein pacing and intermittent fasting (P-IF) are generally safe and well-tolerated for weight loss. Studies have found that P-IF aids in weight loss and improves body shape without major health risks. Participants in those studies did not report serious side effects, indicating these were rare or absent.
The Heart Healthy (HH) diet has also proven safe. It follows guidelines from health organizations like the National Cholesterol Education Program and focuses on lowering bad cholesterol, making it a safe choice for improving heart health.
Both dietary methods have strong safety records, offering promising options for those interested in joining clinical trials.12345Why are researchers excited about this trial?
Researchers are excited about these treatments because they combine low sugar protein pacing with intermittent fasting (P-IF) and a heart-healthy (HH) diet to tackle weight loss in innovative ways. Unlike traditional calorie-restricted diets that often only focus on limiting food intake, the P-IF approach alternates between protein-rich meals and intermittent fasting days, potentially boosting metabolism and enhancing fat loss. Meanwhile, the HH treatment adheres to the National Cholesterol Education Program's guidelines, emphasizing balanced macronutrient intake and fiber, which may improve cardiovascular health alongside weight loss. By exploring these different dietary strategies, this trial aims to uncover more effective and sustainable weight loss methods that might offer additional health benefits.
What evidence suggests that this trial's treatments could be effective for weight loss?
This trial will compare the effects of two different dietary approaches for weight loss. One treatment arm will combine protein pacing with intermittent fasting (P-IF). Studies have shown that this approach can lead to significant weight loss, with participants losing about 9% of their body weight, surpassing those on regular calorie-restricted diets. Participants also experienced a greater reduction in total body fat and belly fat. Specifically, one study found that following this plan for a year resulted in major decreases in weight, waist size, and body fat percentage.
The other treatment arm will follow the Heart Healthy diet, based on guidelines from the National Cholesterol Education Program. This diet is also effective for weight loss, with participants losing at least 5% of their starting weight. U.S. News & World Report ranks this diet highly among weight loss diets. It focuses on low-fat and high-fiber foods, which can help people feel full while consuming fewer calories.12678Who Is on the Research Team?
Paul J Arciero, PhD
Principal Investigator
Skidmore College
Are You a Good Fit for This Trial?
This trial is for overweight or obese non-smoking men and women who have been weight stable for the past 6 months, with no cardiovascular or metabolic diseases. They should be sedentary or lightly active and not pregnant. People with diabetes, significant heart disease, eating disorders, certain allergies, cancer treatments, or fasting intolerances cannot join.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Weight Loss Intervention
Participants follow a dietary intervention phase with protein pacing and intermittent fasting or a heart healthy diet
Follow-up Case Study
Participants are monitored for weight loss maintenance and health improvements over a long-term period
Extended Follow-up
Additional follow-up to document long-term weight loss and body composition improvements
What Are the Treatments Tested in This Trial?
Interventions
- HH
- P-IF
- PP-IF
Find a Clinic Near You
Who Is Running the Clinical Trial?
Skidmore College
Lead Sponsor
Arizona State University
Collaborator
Isagenix International LLC
Industry Sponsor